Clinical Trial Update: Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vonoprazan (TAK-438) with amoxicillin and clarithromycin as first-line therapy for Helicobacter pylori infection; study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Vonoprazan (vonoprazan)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Takeda | Conditions: H. Pylori Infection | Phase 3 | Status: COMPLETED